References
- Arif JM, Al-Saif AM, Al-Karrawi MA, Al-Sagair OA (2011). Causative relationship between diabetes mellitus and breast cancer in various regions of Saudi Arabia: an overview. Asian Pac J Cancer Prev, 12, 589-92.
- Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2011). Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer, 128, 635-43. https://doi.org/10.1002/ijc.25362
- Arcaro A (2013). Targeting the insulin-like growth factor-1 receptor in human cancer. Front Pharmacol, 4, 30.
- Barone BB, Yeh HC, Snyder CF, et al (2008). Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA, 300, 2754-64. https://doi.org/10.1001/jama.2008.824
- Chott A, Sun Z, Morganstern D, et al (1999). Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. Am J Pathol, 155, 1271-9. https://doi.org/10.1016/S0002-9440(10)65229-7
- Currie CJ, Poole CD, Jenkins-Jones S, et al (2012). Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care, 35, 299-304. https://doi.org/10.2337/dc11-1313
- Elena JW, Steplowski E, Yu K, et al (2013). Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control, 24, 13-25. https://doi.org/10.1007/s10552-012-0078-8
- Fidler MJ, Shersher DD, Borgia JA, Bonomi P (2012). Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls. Ther Adv Med Oncol, 4, 51-60. https://doi.org/10.1177/1758834011427576
- Ferguson R, Gallagher EJ, Cohen D, et al (2013). Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2/Neu-mediated breast cancer. Endocr Relat Cancer, 20, 391-401. https://doi.org/10.1530/ERC-12-0333
- Gibson SL, Ma Z, Shaw LM, et al (2007). Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle, 6, 631-7. https://doi.org/10.4161/cc.6.6.3987
- Herberger B, Puhalla H, Lehnert M (2007). Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma. Clin Cancer Res, 13, 4795-9. https://doi.org/10.1158/1078-0432.CCR-07-0738
- Hanbali A, Al-Khasawneh K, Cole-Johnson C, Divine G, Haytham Ali (2007). Protective effect of diabetes against metastasis in patients with non-small cell lung cancer. Arch Intern Med, 167, 513.
- He J, Stram DO, Kolonel LN, et al (2010). The association of diabetes with colorectal cancer risk: the Multiethnic Cohort. Br J Cancer, 103, 120-6. https://doi.org/10.1038/sj.bjc.6605721
- Hardefeldt PJ, Edirimanne S, Eslick GD (2012). Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cancer, 19, 793-803. https://doi.org/10.1530/ERC-12-0242
- Hwang A, Narayan V, Yang YX (2013). Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. Cancer, 119, 404-10. https://doi.org/10.1002/cncr.27731
- Jackson JG, Zhang X, Yoneda T, Yee D (2001). Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Oncogene, 20, 7318-25. https://doi.org/10.1038/sj.onc.1204920
- Kornmann M, Maruyama H, Bergmann U, et al (1998). Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res, 58, 4250-4.
- Kurishima K, Satoh H (2012). Prolonged survival in lung cancer patients with diabetes mellitus. J Thorac Oncol, 7, e17-8. https://doi.org/10.1097/JTO.0b013e3182614877
- LeRoith D, Roberts CT (2003). The insulin-like growth factor system and cancer. Cancer Letters, 195, 127-37. https://doi.org/10.1016/S0304-3835(03)00159-9
- Lee JY, Jeon I, Lee JM, Yoon JM, Park SM (2013). Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studies. Eur J Cancer, 49, 2411-23. https://doi.org/10.1016/j.ejca.2013.02.025
- Pavelic J, Krizanac S, Kapitanovic S, et al (2005). The consequences of insulin-like growth factors/receptors dysfunction in lung cancer. Am J Respir Cell Mol Biol, 32, 65-71. https://doi.org/10.1165/rcmb.2004-0232OC
- Rajpathak SN, Gunter MJ, Wylie-Rosett J,et al (2009). The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev, 25, 3-12. https://doi.org/10.1002/dmrr.919
- Satyamoorthy K., Li G, Vaidya B, Patel D, Herlyn M (2001). Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogenactivated protein kinase and beta-catenin pathways. Cancer Res, 61, 7318-24.
- Shaw LM (2011). The insulin receptor substrate (IRS) proteins: At the intersection of metabolism and cancer. Cell Cycle, 10, 1750-6. https://doi.org/10.4161/cc.10.11.15824
- Siegel R, Naishadham D, Jemal A, et al (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Tan BX, Yao WX, Ge J, et al (2011). Prognostic influence of metformin as first-line chemotherapy for advanced non-small cell lung cancer in patients with type 2 diabetes. Cancer, 117, 5103-11. https://doi.org/10.1002/cncr.26151
- Varlotto J, Medford-Davis LN, Recht A, et al (2012). Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer. Lung Cancer, 75, 381-90. https://doi.org/10.1016/j.lungcan.2011.07.019
- Wu J, Tseng YD, Xu CF, et al (2008). Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nat Struct Mol Biol, 15, 251-8. https://doi.org/10.1038/nsmb.1388
- Wang C, Wang X, Gong G, et al (2012). Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer, 130, 1639-48. https://doi.org/10.1002/ijc.26165
- Wang T, Ning G, Bloomgarden Z (2013). Diabetes and Cancer Relationships. J Diabetes, doi: 10.1111/1753-0407.12057
- Walker JJ, Brewster DH, Colhoun HM, et al (2013). Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000-2007). Diabetologia, 56, 1531-41. https://doi.org/10.1007/s00125-013-2917-x
- Zhang ZH, Su PY, Hao JH, Sun YH (2013). The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies. Int J Gynecol Cancer, 23, 294-303. https://doi.org/10.1097/IGC.0b013e31827b8430
Cited by
- RNA-Seq and Network Analysis Revealed Interacting Pathways in TGF-β-Treated Lung Cancer Cell Lines vol.13s5, pp.1176-9351, 2014, https://doi.org/10.4137/CIN.S14073
- Lack of any Prognostic Role of Insulin-Like Growth Factor-1 Receptor in Non-Small Cell Lung Cancer vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5753
- Anti-Diabetic Medications Do Not Influence Risk of Lung Cancer in Patients with Diabetes Mellitus: a Systematic Review and Meta-analysis vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6863
- Role of Hyperinsulinemia in Increased Risk of Prostate Cancer: A Case Control Study from Kathmandu Valley vol.15, pp.2, 2014, https://doi.org/10.7314/APJCP.2014.15.2.1031
- Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus vol.22, pp.4, 2016, https://doi.org/10.1007/s12253-016-0065-6
- Correlation of the expressions of IGF1R-RACK1-STAT3 and Bcl-xl in nasopharyngeal carcinoma with the clinicopathological features and prognosis of nasopharyngeal carcinoma pp.07302312, 2017, https://doi.org/10.1002/jcb.26354
- The Peroxisome Proliferator-Activated Receptor (PPAR) α Agonist Fenofibrate Suppresses Chemically Induced Lung Alveolar Proliferative Lesions in Male Obese Hyperlipidemic Mice vol.15, pp.5, 2014, https://doi.org/10.3390/ijms15059160
- Insulin-like growth factor 1 receptor expression in advanced non-small-cell lung cancer and its impact on overall survival vol.51, pp.2, 2017, https://doi.org/10.1515/raon-2017-0020
- in High Glucose-Induced SHSY-5Y Cells pp.1557-7430, 2018, https://doi.org/10.1089/dna.2018.4336